Young people with mental health problems who have contact with mental health services are significantly less likely to suffer from clinical depression later in their adolescence than those with equivalent difficulties who do not receive treatment, according to new research from the University of Cambridge. This comes as Prime Minister Theresa May announced measures to improve mental health support at every stage of a person’s life, with an emphasis on early intervention for children and young people.
Modafinil, a drug used to treat narcolepsy – excessive daytime sleepiness – can improve memory in patients recovering from depression, according to new research from the University of Cambridge. The findings, published today in the journal Biological Psychiatry: CNNI, result from a randomised, double-blind, placebo-controlled study and offer hope of a treatment for some of the cognitive symptoms of depression.
Could a Mediterranean diet keep your brain young? That is the tantalising finding from a study out this week. Writing on The Conversation website, Professor Paul Fletcher from the Department of Psychiatry investigates the findings.
DNA sequencing has defined a new genetic disorder that affects movement, enabling patients with dystonia — a disabling condition that affects voluntary movement — to be targeted for treatment that brings remarkable improvements, including restoring independent walking.
More than two-thirds of adolescents who suffer from depression could see long-term benefits from receiving one of three psychological treatments – of which only one is currently recommended on the NHS – according to research published today in The Lancet Psychiatry.
Hard Brexiter or ardent Remainer? Psychologists aim to find out what drives our political ideologies01 Dec 2016
At a time of increasing divisions within politics – think of the recent battles over whether the UK should remain in or leave the European Union – many are asking what it is that drives political ideologies.
New imaging technique measures toxicity of proteins associated with Alzheimer’s and Parkinson’s diseases23 Nov 2016
A new super-resolution imaging technique allows researchers to track how surface changes in proteins are related to neurodegenerative diseases such as Alzheimer’s and Parkinson’s diseases.
Joe Herbert, Emeritus Professor of Neuroscience, explores what we mean by 'gender identity' and asks whether we should insist on an equal gender distribution across occupations and activities.
Researchers have discovered a way to remove specific fears from the brain, using a combination of artificial intelligence and brain scanning technology. Their technique, published in the inaugural edition of Nature Human Behaviour, could lead to a new way of treating patients with conditions such as post-traumatic stress disorder (PTSD) and phobias.